LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J C Neto, Antonio Maia

    Journal of nanoscience and nanotechnology

    2020  Band 20, Heft 12, Seite(n) 7311–7323

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was -9.9 kcal/mol and for the chloroquine of -10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    Mesh-Begriff(e) Adenine/administration & dosage ; Adenine/analogs & derivatives ; Adenine/chemistry ; Adenine/pharmacology ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/chemistry ; Adenosine Monophosphate/pharmacology ; Alanine/administration & dosage ; Alanine/analogs & derivatives ; Alanine/chemistry ; Alanine/pharmacology ; Amides/administration & dosage ; Amides/chemistry ; Amides/pharmacology ; Antiviral Agents/administration & dosage ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Betacoronavirus/drug effects ; Betacoronavirus/enzymology ; Binding Sites ; Chloroquine/administration & dosage ; Chloroquine/chemistry ; Chloroquine/pharmacology ; Coronavirus Infections/drug therapy ; Coronavirus Infections/virology ; Cysteine Endopeptidases/chemistry ; Drug Interactions ; Humans ; Hydrogen Bonding ; Hydroxychloroquine/administration & dosage ; Hydroxychloroquine/chemistry ; Hydroxychloroquine/pharmacology ; Ligands ; Molecular Docking Simulation ; Nanotechnology ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/virology ; Protease Inhibitors/administration & dosage ; Protease Inhibitors/chemistry ; Protease Inhibitors/pharmacology ; Pyrazines/administration & dosage ; Pyrazines/chemistry ; Pyrazines/pharmacology ; Pyrrolidines/administration & dosage ; Pyrrolidines/chemistry ; Pyrrolidines/pharmacology ; Ribavirin/administration & dosage ; Ribavirin/chemistry ; Ribavirin/pharmacology ; Static Electricity ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/chemistry
    Chemische Substanzen Amides ; Antiviral Agents ; Ligands ; Protease Inhibitors ; Pyrazines ; Pyrrolidines ; Viral Nonstructural Proteins ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Ribavirin (49717AWG6K) ; Hydroxychloroquine (4QWG6N8QKH) ; Chloroquine (886U3H6UFF) ; 3C-like proteinase, Coronavirus (EC 3.4.22.-) ; Cysteine Endopeptidases (EC 3.4.22.-) ; favipiravir (EW5GL2X7E0) ; Adenine (JAC85A2161) ; Alanine (OF5P57N2ZX) ; immucillin A (OLF97F86A7)
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-07-23
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 1533-4899
    ISSN (online) 1533-4899
    DOI 10.1166/jnn.2020.18955
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J C Neto, Antonio Maia

    J Nanosci Nanotechnol

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was -9.9 kcal/mol and for the chloroquine of -10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #680345
    Datenquelle COVID19

    Kategorien

  3. Artikel ; Online: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S. Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J. C. Neto, Antonio Maia

    Journal of Nanoscience and Nanotechnology

    2020  Band 20, Heft 12, Seite(n) 7311–7323

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was −9.9 kcal/mol and for the chloroquine of −10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    Schlagwörter General Materials Science ; Bioengineering ; General Chemistry ; Condensed Matter Physics ; Biomedical Engineering ; covid19
    Sprache Englisch
    Verlag American Scientific Publishers
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ISSN 1533-4880
    DOI 10.1166/jnn.2020.18955
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang